NCT01639157已完成不适用
Human Laboratory Study of the Impact of Buspirone Maintenance on the Reinforcing, Subjective and Performance Effects of Cocaine
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 9
- 试验地点
- 1
- 主要终点
- Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative
研究概览
简要总结
Cocaine use disorders are an unrelenting public health concern. Intensive research efforts have yielded behavioral interventions that reduce cocaine use, however, these interventions are not universally effective and treatment effects diminish over time. Development of a pharmacotherapy that enhances the efficacy of these interventions is a priority for the National Institute on Drug Abuse. This study proposes to determine the impact of buspirone maintenance on self-administration of cocaine and alternative reinforcers. These preliminary data will be used to support further research developing buspirone as a pharmacotherapy for cocaine use disorders. We hypothesize that buspirone will attenuate the reinforcing effects of cocaine and increase the reinforcing effects of alternative reinforcers.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Recent cocaine use
排除标准
- •Abnormal screening outcome (e.g., ECG, blood chemistry result) that study physicians deem clinically significant
- •Current or past histories of substance abuse or dependence that are deemed by the study physicians to interfere with study completion
- •History of serious physical disease, current physical disease, impaired cardiovascular functioning, chronic obstructive pulmonary disease, history of seizure or current or past histories of serious psychiatric disorder that in the opinion of the study physician would interfere with study participation will be excluded from participation
- •Females not currently using effective birth control
- •Contraindications to cocaine or buspirone
研究组 & 干预措施
Buspirone
Experimental
Subjects will be maintained on 30 mg buspirone daily.
干预措施: Buspirone (Drug)
Placebo
Placebo Comparator
Subjects will be maintained on placebo (i.e., 0 mg buspirone daily).
干预措施: Placebo (Drug)
结局指标
主要结局
Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative
时间窗: One test per cocaine dose level per intervention for each participant over his/her 2 week inpatient admission
The reinforcing effects of cocaine were determined using a modified progressive ratio procedure (Stoops et al., 2010) in which subjects made 6 choices between available each available cocaine dose and money (US$0.25). Reinforcing effects are measured for each cocaine dose during both buspirone and placebo maintenance.
次要结局
- Peak Score on Sedative Subscale of the Adjective Rating Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "High" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Irregular/Racing Heartbeat" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Like Drug" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Systolic Blood Pressure(This measure was completed at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Score on Stimulant Subscale of the Adjective Rating Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Active, Alert, Energetic" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Any Effect" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Bad Effects" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Euphoric" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Good Effects" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Nauseated, Queasy, Sick to Stomach" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Nervous, Anxious" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Willing to Pay For" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Performance Impaired" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Performance Improved" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Restless" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Rush" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Shaky, Jittery" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Sluggish, Fatigued, Lazy" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Stimulated" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Willing to Take Again" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Ratings of "Talkative, Friendly" on the Visual Analog Scale(Subjects completed this measure at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Oral Temperature(This measure was completed at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Diastolic Blood Pressure(This measure was completed at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
- Peak Heart Rate(This measure was completed at 15 minute intervals for 45 minutes after sampling each cocaine dose under both buspirone and placebo maintenance conditions.)
研究者
William Stoops
Assistant Professor
University of Kentucky
研究点 (1)
Loading locations...
相似试验
撤回
2 期
Human Behavioral Pharmacology Laboratory Study of Varenicline's Impact on Cocaine ReinforcementCocaine DependenceNCT01143857Jennifer Plebani
已完成
2 期
Cocaine Abuse and ADHD - 10Cocaine-Related DisordersNCT00000275National Institute on Drug Abuse (NIDA)16
已完成
1 期
Buspirone as a Candidate Medication for Methamphetamine AbuseMethamphetamine DependenceMethamphetamine AbuseNCT01843205University of Kentucky9
已完成
2 期
Cocaine Use Reduction With BuprenorphineCocaine DependenceNCT01402492University of California, Los Angeles302
已完成
不适用
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine UseCocaine Use DisorderNCT02444208University of Kentucky40